APA (7th ed.) Citation

JS, Y., S, P., Y, H., K, M., FJ, G., AA, V., & AM, B. (2022). Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines. Cardiovascular drugs and therapy, 36(4), 589. https://doi.org/10.1007/s10557-021-07169-z

Chicago Style (17th ed.) Citation

JS, Yi, Perla S, Huang Y, Mizuno K, Giordano FJ, Vinks AA, and Bennett AM. "Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines." Cardiovascular Drugs and Therapy 36, no. 4 (2022): 589. https://doi.org/10.1007/s10557-021-07169-z.

MLA (9th ed.) Citation

JS, Yi, et al. "Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines." Cardiovascular Drugs and Therapy, vol. 36, no. 4, 2022, p. 589, https://doi.org/10.1007/s10557-021-07169-z.

Warning: These citations may not always be 100% accurate.